Introduction
The use of natural products in the treatment of disease has been an important component of medical therapy for centuries. Plants of the family Euphorbiaceae have been used to treat cancers, tumors, and warts for hundreds of years, and references to their use have appeared in the literature of many countries (1).
We report here the isolation and characterization of two stereoisomeric cyclic triterpenes 1 and 2 from leaves of Euphorbia pulcherrima Willd. Their synthesis from cycloartenol is also described. The isolated triterpenes show significant inhibitory activity against Ehrlich ascites tumor cells in culture. As the content of these triterpenoids in E. pulcherrima is very small (about 0.05 parts per thousand), it was necessary to find other sources. From Artocarpus integnfolia Forst. (2) we have isolated the same triterpenes in small quantities and we have also isolated cylcoartenone and cylcoartenol. 
Materials and Methods

Plant material
Leaves of
Cell culture
Ehrlich ascites tumor cells, originally isolated from murine cancer mammae were adapted to suspension culture and kept in exponential growth by daily dilution with Eagle's minimum essential medium with Earle's salts supplemented with 10 % heat-inactivated fetal calf serum, 1001U/ml streptomycinpenicillin, and HEPES buffer (pH 7.3) to a final concentration of 15 mM, and non-essential amino acids (all from Gibco, Paisley, Scotland). Cells were exposed to drugs for 24 hours at 37 °C with appropriate controls. Cell growth was evaluated from cell counts using a hemocytometer, and the number of living cells was determined by the Trypan blue dye exclusion test. The cells were subcultured at a density of 2 x 105 cells/ml in 5 ml medium. Cholesterol and mevalonic acid used in drug combination studies were purchased from Sigma Chemical Co. (St. Louis, MO, U. S.A. ).
Cell cytotoxicity assay
Ehrlich ascites tumor cells were seeded into separate flasks at a cell density of 2 x 105 cells/ml. Compounds dissolved in 96 % ethanol were added to give desired concentrations. The ethanol concentration did not exceed 0.5 % in any experiment.
Cells were incubated with compounds for 24 h in an orbital shaker incubator holding 37 °C. After incubation aliquots were removed and cell toxicity evaluated by differential counting of trypan blue stained cells.
Chromatography
For medium pressure chromatography (MPLC), a Buchi MPLC column, 4.9 x 92 cm filled with silica gel (230 -400 mesh, Merck, Darmstadt, Germany) and coupled to a Bfichi B-681 pump (BUN, Flawil, Switzerland) was employed. Centrifugally accelerated radial chromatography was performed on a Chromatotron model 7924T (Harrison Research, Palo Alto, CA, USA) using 2-mm layers of silica gel PF254 (Merck). For HPTLC, silica gel 60F254 plates (Merck) were used, and spots were visualized by spraying with anisaldehyde reagent (18 : 1 : 1 anisaldehyde : H2SO4 : CH3COOH), 6 % in ethanol.
Extraction and purification
Air-dried leaves of E. pulcherrima (300 g) were powdered and percolated at room temperature with 31 petroleum ether (bp 60 -80 °C) for 24 hours. Concentration of the extract in vacuo yielded 18 g of residue. Of this, 13 g were dissolved in toluene, filtered, and chromatographed (MPLC) with petroleum ether (21), toluene (21), toluene + 5 % ethyl acetate (41), toluene + 7 % ethyl acetate (41), and 11 portions of 10 %,12.5 %,15 %, 20 %, and 40 % ethyl acetate in toluene. Fractions of 250 ml were collected, and the cytotoxicity of the fractions was monitored by tests using Ehrlich ascites tumor cells in suspension culture. Three cytotoxic fractions were collected: A (86.5 mg with 10 % ethyl acetate in toluene), B (45 mg with 12.5 % ethyl acetate in toluene) and C (210 mg with 20 % ethyl acetate in toluene).
The active fractions were further purified by centrifugally accelerated radial chromatography with hexane-ethyl acetate (6: 1, v/v) as eluent. Fifteen fractions of 10 -15 ml each were collected and monitored by HPTLC (hexane-ethyl acetate, 2 :1). The fractions were also tested for cytotoxicity.
Four of the fractions obtained from A showed significant cytotoxic activity. The most active of these fractions crystallized on evaporation of solvent (6.7 mg) and showed one spot on HPTLC (Rf = 0.46). The substance was identified as the triterpenoid 9,19-cycloart-25-ene-30,24-diol (2) by comparison of the spectral data of the substance and its acetate (1H-NMR, 13C-NMR, IR, El-mass) with the literature values (3 -6).
Among the fractions from C, 6 showed significant cytotoxic activity. The most active fraction was crystallized by evaporation (9.1 mg) and showed one spot on HPTLC (Rf = 0.37). The substance was similarly identified as 9,19-cycloart-23-ene-3/3,25-diol (1).
MPLC fraction B contained a mixture of these two compounds.
Synthesis of 1 and 2
Cycloartenol: Reduction of cycloartenone (7.53 g) with LiA1H4 in ether gave the a-and /3-epimers in a 26 : 74 ratio, respectively, according to the 1H-NMR spectrum showing the C3-H as two well separated double doublets. The assignment of the f3-isomer was based on comparison of both the 1 H-and 13C-NMR spectra in the literature (7). The other product formed was assumed to be the a-epimer since it formed cycloartenone upon oxidation. Flash chromatography (silica gel, 230 -400 mesh, 80 g : 4 g crude product, hexane-ethyl acetate 8 : 2) gave the pure /3-isomer. In a separate experiment, it was found much easier to separate the two epimers as their acetates. 1H-NMR (270 MHz, CDC13) of cycloartenol: 8 = 3.28 (dd, J1 = 4.4, J2 --10.9 Hz, C3-H, /3-epimer), 3.48 (dd, J1 = 6.9, J2 = 13.8 Hz, C3-H, a-epimer). Yield: 5.08 g, 67 % based on starting cycloartenone, 91 % based on separated a-epimer. The latter epimer could be recycled by oxidation followed by a new reduction.
Cycloartenol acetate was made in quantitative yield using pyridine and acetic anhydride. Flash chromatography (silica gel, 230 -400 mesh, 80 g : 6 g crude acetate, hexane-ethyl acetate 9 :1) gave the pure product.
Cycloart-25-ene-3 f3,24-diol and cycloart-23-ene-3/3,25-dial were made in a modification of a previous synthesis (8) . To a solution of 5.58 g (11.9 mmol) cycloartenyl acetate in 450 ml pyridine was added 1.30 g hematoporphyrine. The solution was kept at room temperature by means of a water bath and oxygen was bubbled through via a glass sinter. The mixture was irradiated using a 250 W immersion high pressure mercury lamp with a pyrex filter. The reaction was monitored by TLC (silica gel, hexane-ethyl acetate, 97.5 : 2.5) and was stopped when all starting material had disappeared (2 h). Most of the pyridine was evaporated on a rotary evaporator (not to dryness), 400 ml absolute ether was added and the product reduced by the portionwise addition of 3.46g (91.2 mmol) LiA1H4. Stirring for 2 h at room temperature followed by the successive addition of 3.5 ml water, 3.5 ml 15 % NaOH (aq) and 10.5 ml water with vigorous stirring, filtering and evaporation gave a dark oil. According to 1 H-NMR of the crude mixture, the two compounds had formed in a 35 : 65 ratio, respectively. Flash chromatography (silica gel, 230 -400 mesh, 80 g : 3 g crude product, hexane-ethyl acetate 75 : 25) separated the two compounds. Spectroscopic and physical data were in accord with the literature (3 -6).
Results
Cell inactivating effect
The isomeric compounds 9,19-cycloart-23-ene-3/3,25-diol (1) and 9,19-cycloart-25-ene-3/3,24-diol (2) were dissolved in ethanol. The cytotoxic activity was assayed using three different concentrations (Fig. 1) . Both isolated triterpenes exhibited cell inactivating effects. The IC50 is approximately 7.5µM, while the IC90 is approximately 13.5 µM for 9,19-cycloart-25-ene-316,24-diol. The 3/3,25-diol compound is 50 % less active. Acetylation of 9,19-cycloart-23-ene-3/3,25-diol did not change the activity of the substance, whereas acetylation of 9,19-cycloart-25-ene-3/3,24-diol resulted in inactivation of the substance (Fig. 1, open circles) .
The triterpenes probably arise biogenetically by oxidation of cycloartenol which is an intermediate in the biosynthesis of plant steroids, and is a common constituent of Euphorbia (9) . Cycloartenol showed no activity against Ehrlich ascites tumor cells up to a concentration of 100 µg/ml (Fig. 1, open triangles) . 
Effects of cholesterol and mevalonic acid
As indicated above, the cytotoxic effect of 9,19-cycloart-25-ene-3 /3,24-diol is irreversible. Neither addition of cholesterol up to 15µM nor mevalonic acid (1 mM) reversed cytotoxicity induced by the cycloartenol derivative ( Table 1) . 
Irreversible effect of 9,19-cydoart-25-ene-313,24-diol
Ehrlich ascites tumor cells were treated for 4 hours, the cells were centrifuged, washed with PBS, and finally resuspended in medium for a further 20 hour incubation (Fig. 2) . The results show that the effect of 9,19-cycloart-25-ene-3/3,24-diol is irreversible.
Discussion
Our results show that the stereoisomeric triterpenes isolated from the leaves of Euphorbia pulcherrima are cytotoxic towards Ehrlich ascites tumor cells. Acetylation of the diol 9,19-cycloart-23-ene-3/3,25-diol (1) does not result in the formation of a 25-acetoxy group (14) as indicated by the NMR spectra of the diol and its monoacetate. The other diol, 9,19-cycloart-25-ene-36,24-diol (2), is isomeric with the former, but in contrast it readily formed a diacetate.
The cytotoxic effect of substance 1 did not change after acetylation in contrast to substance 2 which lost its cytotoxic effect after acetylation (Fig. 1) . From this it can be inferred that the OH group in the 3-position is not essential for the cytotoxic effect. The cytotoxic effect of the cycloartenol derivative 9,19-cycloart-25-ene-3/3,24-diol is irreversible (Fig. 2) and the effect cannot be reversed by cholesterol or mevalonic acid ( Table 1) . This implies that the primary effect of the substance cannot be on HMG-CoA reductase. This is in contrast to the report of Defay et al. (15) who found 100% inhibition of HMG-CoA reductase from human lymphocytes.
Cycloartenol has previously been identified as the main tri-
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terpene alcohol from latex of E. pulcherrima (16) . Cycloartenol, the putative precursor of 1 and 2, induced, as expected, no cytotoxic activity. Further experimentation to elucidate the mechanism and specificity of the cytotoxic effect induced by 9,19-cycloart-25-ene-3fl,24-diol is currently in progress.
